Sandoz Group AG (LON:0SAN)

London flag London · Delayed Price · Currency is GBP · Price in CHF
38.40
+0.43 (1.14%)
At close: May 15, 2025
20.05%
Market Cap 14.88B
Revenue (ttm) 8.29B
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE 13.78
Dividend 0.55 (1.45%)
Ex-Dividend Date Apr 17, 2025
Volume 22,877
Average Volume 445,454
Open 37.77
Previous Close 37.97
Day's Range 37.66 - 38.41
52-Week Range 23.50 - 33.14
Beta n/a
RSI 62.43
Earnings Date Aug 7, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange London Stock Exchange
Ticker Symbol 0SAN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.